Application of Quality by Design in Drug Substance Process Development | AIChE

Application of Quality by Design in Drug Substance Process Development

Chair(s)

Nere, N., AbbVie Inc.

Co-chair(s)

Wei, H., University of Illinois at Chicago

The pharmaceutical industry is increasingly implementing Quality by Design (QbD) to ensure robust and efficient processing through novel applications of process knowledge, technology, and risk management. Speakers for this session should include topics describing their application of QbD principles with examples such as determining critical process parameters (CPPs), mapping of design spaces (DS), controlling processes in real-time, and the developing appropriate control strategies for small and large molecule drug substance processes.

Presentations

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing

Individuals

2015 AIChE Annual Meeting Proceedings
AIChE Pro Members $150.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $225.00
Non-Members $225.00
Pharmaceutical Discovery, Development and Manufacturing Forum only
AIChE Pro Members $100.00
Food, Pharmaceutical & Bioengineering Division Members Free
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $150.00
Non-Members $150.00